Literature DB >> 20692721

[Central retinal vein and artery occlusions related to intraocular involvement of an anaplastic optochiasmatic glioma].

S Dumas-Stoeckel1, J Gambrelle, P L Cornut, H El Chehab, A Vighetto, P Denis.   

Abstract

Malignant optic tract gliomas are very aggressive and extremely rare tumors progressing to blindness and death in a few months. We report here the case of a 73-year-old patient who presented a sudden decrease in visual acuity in his left eye associated with papilledema and headache: it revealed an optochiasmatic anaplastic glioma. A few months later, the glioma had grown, with infiltration of the right optic nerve and right peripapillary intraocular invasion. Through this case, we discuss the importance of achieving imaging for atypical optic neuropathies and stress the exceptional nature of intraocular invasion by a glioma.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20692721     DOI: 10.1016/j.jfo.2010.06.014

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  4 in total

Review 1.  Malignant optic glioma - the spectrum of disease in a case series.

Authors:  Ghislaine L Traber; Athina Pangalu; Manuela Neumann; Joao Costa; Michael Weller; Ruth Huna-Baron; Klara Landau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

2.  Central Retinal Vein Occlusion in a Childhood Optic Nerve Tumour.

Authors:  Igor Kozak; Sahar M Elkhamary; Thomas M Bosley
Journal:  Neuroophthalmology       Date:  2016-01-19

3.  Malignant optic nerve glioma in a young woman with 7 year follow up without recurrence.

Authors:  Chris R Alabiad; Veeral S Shah; Tiffany A Eatz; Linda L Sternau; Byron L Lam
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-11

4.  Glioblastoma multiforme mimicking optic neuritis.

Authors:  Meera S Ramakrishnan; Robin A Vora; Aubrey L Gilbert
Journal:  Am J Ophthalmol Case Rep       Date:  2020-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.